23 related articles for article (PubMed ID: 14506181)
1. Recent progress in the imaging of c-Met aberrant cancers with positron emission tomography.
Floresta G; Abbate V
Med Res Rev; 2022 Jul; 42(4):1588-1606. PubMed ID: 35292998
[TBL] [Abstract][Full Text] [Related]
2. Imaging c-Met expression using 18F-labeled binding peptide in human cancer xenografts.
Li W; Zheng H; Xu J; Cao S; Xu X; Xiao P
PLoS One; 2018; 13(6):e0199024. PubMed ID: 29894497
[TBL] [Abstract][Full Text] [Related]
3. Analysis of progress and challenges for various patterns of c-MET-targeted molecular imaging: a systematic review.
Han Z; Wu Y; Wang K; Xiao Y; Cheng Z; Sun X; Shen B
EJNMMI Res; 2017 Dec; 7(1):41. PubMed ID: 28485003
[TBL] [Abstract][Full Text] [Related]
4. Design and Feasibility Study of a Single Photon Emission Microscope System for Small Animal I-125 Imaging.
Meng LJ; Clinthorne NH; Skinner S; Hay RV; Gross M
IEEE Trans Nucl Sci; 2006 Jun; 53(3):1168-1178. PubMed ID: 28255179
[TBL] [Abstract][Full Text] [Related]
5. Theranostic applications of antibodies in oncology.
Fleuren ED; Versleijen-Jonkers YM; Heskamp S; van Herpen CM; Oyen WJ; van der Graaf WT; Boerman OC
Mol Oncol; 2014 Jun; 8(4):799-812. PubMed ID: 24725480
[TBL] [Abstract][Full Text] [Related]
6. A novel multipurpose monoclonal antibody for evaluating human c-Met expression in preclinical and clinical settings.
Knudsen BS; Zhao P; Resau J; Cottingham S; Gherardi E; Xu E; Berghuis B; Daugherty J; Grabinski T; Toro J; Giambernardi T; Skinner RS; Gross M; Hudson E; Kort E; Lengyel E; Ventura A; West RA; Xie Q; Hay R; Vande Woude G; Cao B
Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):57-67. PubMed ID: 18815565
[TBL] [Abstract][Full Text] [Related]
7. Construction of human naïve Fab library and characterization of anti-met Fab fragment generated from the library.
Jiao Y; Zhao P; Zhu J; Grabinski T; Feng Z; Guan X; Skinner RS; Gross MD; Hay RV; Tachibana H; Cao B
Mol Biotechnol; 2005 Sep; 31(1):41-54. PubMed ID: 16118414
[TBL] [Abstract][Full Text] [Related]
8. Radio-immunotargeting in experimental animal models of intraperitoneal cancer.
Fjeld JG; Vergote I; De Vos L; Nustad K
Acta Obstet Gynecol Scand Suppl; 1992; 155():105-11. PubMed ID: 1502887
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunoscintigraphy of human met-expressing tumor xenografts using met3, a new monoclonal antibody.
Hay RV; Cao B; Skinner RS; Wang LM; Su Y; Resau JH; Knudsen BS; Gustafson MF; Koo HM; Vande Woude GF; Gross MD
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3839S-44S. PubMed ID: 14506181
[TBL] [Abstract][Full Text] [Related]
10. Nuclear imaging of Met-expressing human and canine cancer xenografts with radiolabeled monoclonal antibodies (MetSeek).
Hay RV; Cao B; Skinner RS; Su Y; Zhao P; Gustafson MF; Qian CN; Teh BT; Knudsen BS; Resau JH; Shen S; Waters DJ; Gross MD; Vande Woude GF
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7064s-7069s. PubMed ID: 16203803
[TBL] [Abstract][Full Text] [Related]
11. Identification of a met-binding peptide from a phage display library.
Zhao P; Grabinski T; Gao C; Skinner RS; Giambernardi T; Su Y; Hudson E; Resau J; Gross M; Vande Woude GF; Hay R; Cao B
Clin Cancer Res; 2007 Oct; 13(20):6049-55. PubMed ID: 17947467
[TBL] [Abstract][Full Text] [Related]
12. Enhanced growth of human met-expressing xenografts in a new strain of immunocompromised mice transgenic for human hepatocyte growth factor/scatter factor.
Zhang YW; Su Y; Lanning N; Gustafson M; Shinomiya N; Zhao P; Cao B; Tsarfaty G; Wang LM; Hay R; Vande Woude GF
Oncogene; 2005 Jan; 24(1):101-6. PubMed ID: 15531925
[TBL] [Abstract][Full Text] [Related]
13. Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.
Burgess T; Coxon A; Meyer S; Sun J; Rex K; Tsuruda T; Chen Q; Ho SY; Li L; Kaufman S; McDorman K; Cattley RC; Sun J; Elliott G; Zhang K; Feng X; Jia XC; Green L; Radinsky R; Kendall R
Cancer Res; 2006 Feb; 66(3):1721-9. PubMed ID: 16452232
[TBL] [Abstract][Full Text] [Related]
14. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts.
Kim KJ; Wang L; Su YC; Gillespie GY; Salhotra A; Lal B; Laterra J
Clin Cancer Res; 2006 Feb; 12(4):1292-8. PubMed ID: 16489086
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
